Arnhold LLC - NEWLINK GENETICS CORP ownership

NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 66 filers reported holding NEWLINK GENETICS CORP in Q4 2019. The put-call ratio across all filers is 5.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
Arnhold LLC ownership history of NEWLINK GENETICS CORP
ValueSharesWeighting
Q3 2019$16,000
+6.7%
10,0000.0%0.00%0.0%
Q2 2019$15,000
-21.1%
10,0000.0%0.00%0.0%
Q1 2019$19,000
+26.7%
10,0000.0%0.00%0.0%
Q4 2018$15,000
-96.5%
10,000
-94.5%
0.00%
-96.0%
Q3 2018$434,000
-63.0%
181,740
-26.2%
0.08%
-63.6%
Q2 2018$1,173,000
-45.8%
246,340
-17.4%
0.21%
-49.6%
Q1 2018$2,163,000298,4000.41%
Other shareholders
NEWLINK GENETICS CORP shareholders Q4 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 93,533$962,0001.69%
WALL STREET ASSOCIATES 108,900$1,119,0000.74%
NORTHWEST WEALTH MANAGEMENT, LLC 57,482$591,0000.60%
Orbimed Advisors 1,991,700$20,475,0000.26%
TFS CAPITAL LLC 92,041$946,0000.25%
Intrinsic Edge Capital Management LLC 40,000$411,0000.18%
SECOR Capital Advisors, LP 100,529$1,033,0000.13%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 176,077$1,810,0000.12%
Piermont Capital Management Inc. 41,400$426,0000.10%
Vident Investment Advisory, LLC 67,209$691,0000.08%
View complete list of NEWLINK GENETICS CORP shareholders